Home › NDC Lookup › RxCUI directory › RxCUI 1435495

Benzocaine 200 MG/ML Oral Spray [Gelato Anesthetic] — RxCUI 1435495

RxNorm drug concept · Semantic branded drug
RxCUI 1435495 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1435495
Official nameBenzocaine 200 MG/ML Oral Spray [Gelato Anesthetic]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asGelato Anesthetic 20 % Oral Spray; Gelato Anesthetic 200 MG/ML Oral Spray
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Benzocaine 200 MG/ML Oral Spray [Gelato Anesthet... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Benzocaine 200 MG/ML Oral Spray [Gelato Anesthetic] RxCUI 1435495

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Benzocaine 1399
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Gelato Anesthetic 727985
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Benzocaine Oral Spray 379313
    • Benzocaine Oral Liquid Product 1152968
    • Benzocaine Oral Product 1152969
    • Benzocaine Oral Spray Product 1295408
    • Benzocaine Oral Spray [Gelato Anesthetic] 1435492
    • Gelato Anesthetic Oral Liquid Product 1435493
    • Gelato Anesthetic Oral Product 1167701
    • Gelato Anesthetic Oral Spray Product 1435494
    • +4 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Benzocaine 200 MG/ML Oral Spray SCD · 1435490
  • Benzocaine 200 MG/ML SCDC · 328676
  • Benzocaine Oral Spray SCDF · 379313
  • Benzocaine Oral Liquid Product SCDG · 1152968
  • Benzocaine Oral Product SCDG · 1152969
  • Benzocaine Oral Spray Product SCDG · 1295408

Brand-Name Concepts

  • Benzocaine 200 MG/ML [Gelato Anesthetic] SBDC · 1435491
  • Benzocaine Oral Spray [Gelato Anesthetic] SBDF · 1435492
  • Gelato Anesthetic Oral Liquid Product SBDG · 1435493
  • Gelato Anesthetic Oral Product SBDG · 1167701
  • Gelato Anesthetic Oral Spray Product SBDG · 1435494
  • Gelato Anesthetic BN · 727985

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1435495 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68400-0323-35 57 g in 1 BOTTLE, SPRAY (68400-323-35) Gelato Topical Anesthetic Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc 2018-09-01
Observed labelers: Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.